NCT00734461View on ClinicalTrials.gov

Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Opioid-Related Disorders
Interventions
DRUG

oxycodone and naltrexone

"tablets containing 20 mg or 40 mg oxycodone~/ tablets containing 20 mg or 40 mg oxycodone combined w/0.001 mg or 0.0001 mg naltrexone"

Trial Locations (1)

21224-6823

Behavioral Pharmacology Research Unit, Baltimore

Sponsors

Lead Sponsor

Pain Therapeutics
All Listed Sponsors
lead

Pain Therapeutics

INDUSTRY

NCT00734461 - Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse | Biotech Hunter | Biotech Hunter